Successful dupilumab treatment for omalizumab-refractory chronic spontaneous urticaria with GATA3+ cell infiltration
Authors:
- Kaho ShiraiKSKaho Shirai
- Takahiro SuzukiTSTakahiro Suzuki
- Yuka NagakuraYNYuka Nagakura
- Tetsuya HondaTHTetsuya Honda
- 1 June 2026
- journal article
- Published by JLE in European Journal Of Dermatology
- Vol. 36 (3) , 277-279